XTNT (Xtant Medical Holdings) Days Payable: 47.75 (As of Mar. 2026) — 13% Below Median


XTNT Xtant Medical Holdings Inc XTNT
31 GF Score
Price $0.42
GF Value $0.62
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Xtant Medical Holdings Days Payable?

Xtant Medical Holdings XTNT -0.33% 31 Days Payable is 47.75 as of Mar. 2026, which is 13% below its 10-year median of 54.71. GuruFocus rates XTNT with a GF Score™ of 31/100 and a GF Value™ of $0.62 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Xtant Medical Holdings ranks worse than 67.17% on this metric.

Xtant Medical Holdings's average Accounts Payable for the three months ended in Mar. 2026 was $4.7 Mil. Xtant Medical Holdings's Cost of Goods Sold for the three months ended in Mar. 2026 was $8.9 Mil. Hence, Xtant Medical Holdings's Days Payable for the three months ended in Mar. 2026 was 47.75.

The historical rank and industry rank for Xtant Medical Holdings's Days Payable or its related term are showing as below:

XTNT' s Days Payable Range Over the Past 10 Years
Min: 43.13   Med: 54.71   Max: 130.79
Current: 48.55

During the past 13 years, Xtant Medical Holdings's highest Days Payable was 130.79. The lowest was 43.13. And the median was 54.71.

XTNT's Days Payable is ranked worse than
67.17% of 795 companies
in the Medical Devices & Instruments industry
Industry Median: 67.87 vs XTNT: 48.55

Xtant Medical Holdings's Days Payable declined from Mar. 2025 (54.19) to Mar. 2026 (47.75). It may suggest that Xtant Medical Holdings accelerated paying its suppliers.


Xtant Medical Holdings Days Payable Historical Data

* Premium members only.

The historical data trend for Xtant Medical Holdings's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xtant Medical Holdings Days Payable Chart

Xtant Medical Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 44.57 43.13 53.70 55.71 43.23

Xtant Medical Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.19 58.82 57.03 33.43 47.75

XTNT vs MDAI, QTI, POSC: Days Payable Comparison

For the Medical Devices subindustry, Xtant Medical Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xtant Medical Holdings Days Payable vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xtant Medical Holdings's Days Payable distribution charts can be found below:

* The bar in red indicates where Xtant Medical Holdings's Days Payable falls into.


XTNT
31GF Score
Xtant Medical Holdings Inc XTNT
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Xtant Medical Holdings Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Xtant Medical Holdings's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (7.918 + 3.844) / 2 ) / 49.654*365
=5.881 / 49.654*365
=43.23

Xtant Medical Holdings's Days Payable for the quarter that ended in Mar. 2026 is calculated as:

Days Payable (Q: Mar. 2026 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2025 ) + Accounts Payable (Q: Mar. 2026 )) / count ) / Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=( (3.844 + 5.485) / 2 ) / 8.913*365 / 4
=4.6645 / 8.913*365 / 4
=47.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 47.75 mean?
Xtant Medical Holdings (XTNT) has a Days Payable of 47.75 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Xtant Medical Holdings and its competitors. This is 13% below median its historical median of 54.71. Over the past decade, Xtant Medical Holdings' Days Payable has ranged from 43.13 to 130.79. According to the industry distribution chart, Xtant Medical Holdings ranks #534 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 67.2%.
Is Xtant Medical Holdings' Days Payable too high?
Xtant Medical Holdings' current Days Payable of 47.75 is 13% below median its 10-year median of 54.71. Over the past 10 years, this metric has ranged from a low of 43.13 to a high of 130.79. The Medical Devices & Instruments industry median Days Payable is 67.87. Xtant Medical Holdings' value of 47.75 is 29.6% below this industry median. Based on the distribution chart, Xtant Medical Holdings ranks #534 out of 795 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Xtant Medical Holdings has a GF Score™ of 31/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Xtant Medical Holdings' Days Payable compare to MDAI and QTI?
According to the Medical Devices & Instruments industry distribution chart, Xtant Medical Holdings ranks #534 out of 795 companies for Days Payable. This places Xtant Medical Holdings in the lower half of its industry. The industry median Days Payable is 67.87. Xtant Medical Holdings' value of 47.75 is 29.6% below this benchmark. Historically, Xtant Medical Holdings' own Days Payable has ranged from 43.13 to 130.79 over the past decade. While the company's 10-year median is 54.71 vs. the industry median of 67.87, Xtant Medical Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Xtant Medical Holdings's current Days Payable of 47.75 is 29.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Xtant Medical Holdings and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Xtant Medical Holdings's current Days Payable is 47.75, which is 13% below median its own 10-year median of 54.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xtant Medical Holdings stock overvalued right now?
Based on GuruFocus' analysis, Xtant Medical Holdings (XTNT) is currently considered Possible Value Trap. The stock's GF Value™ is $0.62, compared to a current price of $0.42 — trading 32.2% below its estimated fair value. The current Days Payable is 47.75, which is 13% below median its 10-year median of 54.71 and 29.6% below the Medical Devices & Instruments industry median of 67.87. Xtant Medical Holdings' overall GF Score™ is 31/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Xtant Medical Holdings (XTNT), the current Days Payable is 47.75 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Xtant Medical Holdings (XTNT) Overvalued in 2026?

Based on GuruFocus' analysis, Xtant Medical Holdings stock appears to be undervalued. The current stock price of $0.42 is trading 32.2% below its estimated GF Value™ of $0.62. GuruFocus considers Xtant Medical Holdings to be Possible Value Trap.

Key valuation signals for XTNT:

  • Days Payable: 47.75 (13% below median its 10-year median of 54.71)
  • GF Value™: $0.62 vs. price of $0.42 (32.2% below fair value)
  • GF Score™: 31/100 with 4 warning signs
  • Industry Position: 29.6% below the Medical Devices & Instruments median (#534 of 795)

No single metric tells the full story. See the XTNT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Xtant Medical Holdings Business Description

Address 664 Cruiser Lane, Belgrade, MT, USA, 59714
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
31GF Score

Get the complete analysis for XTNT

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.42
Price
$0.62
GF Value